Contrast-induced nephropathy: Pathogenesis and prevention

Pediatric Nephrology

Volumn 25, Issue 2, 2010, Pages 191-204

  Cronin, Robert E ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Contrast media; Hemofiltration; Kidney; Pathogenesis; Prevention

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; FUROSEMIDE; GADOLINIUM; IODIXANOL; IOTALAMIC ACID; IOVERSOL; IOXAGLIC ACID; ISOTONIC SOLUTION; MANNITOL; PLACEBO; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; CONTRAST MEDIUM;

CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CONTRAST RADIOGRAPHY; CREATININE BLOOD LEVEL; CYTOTOXICITY; DIABETIC NEPHROPATHY; DRUG EXCRETION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPOXIA; KIDNEY INJURY; KIDNEY MEDULLA; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; URINARY EXCRETION; CHEMICALLY INDUCED DISORDER; HEALTH CARE PLANNING; KIDNEY DISEASE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; CONTRAST MEDIA; HEALTH PLANNING GUIDELINES; HUMANS; ISOTONIC SOLUTIONS; KIDNEY DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SODIUM BICARBONATE; SODIUM CHLORIDE;

EID: 77950486314     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1204-z     Document Type: Review

References (139)

1. 1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2006) Heart disease and stroke statistics-2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85-e151
2. Persson PB (2005) Editorial: Contrast medium-induced nephropathy. Nephrol Dial Transplant 20[Suppl 1]:i1
3. Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, Palevsky PM (2006) Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17:2871-2877 (Pubitemid 44484677)
4. Liss P, Persson PB, Hansell P, Lagerqvist B (2006) Renal failure in 57 925 patients undergoing coronary procedures using isoosmolar or low-osmolar contrast media. Kidney Int 70:1811-1817 (Pubitemid 44684813)
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW (1997) Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103:368-375 (Pubitemid 27506242)
6. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259-2264 (Pubitemid 34535335)
7. Solomon R, Barrett B (2006) Follow-up of patients with contrast-induced nephropathy. Kidney Int Suppl:S46-50
8. Katholi RE, Taylor GJ, Woods WT, Womack KA, Katholi CR, McCann WP, Moses HW, Dove JT, Mikell FL, Woodruff RC, Miller BD, Schneider JA (1993) Nephrotoxicity of nonionic lowosmolality versus ionic high-osmolality contrast media: A prospective double-blind randomized comparison in human beings. Radiology 186:183-187
9. Shah SH, Mehta RL (2006) Acute kidney injury in critical care: Time for a paradigm shift? Curr Opin Nephrol Hypertens 15:561-565
10. Hoste EA, Kellum JA (2006) Acute kidney injury: Epidemiology and diagnostic criteria. Curr Opin Crit Care 12:531-537 (Pubitemid 44673427)
11. Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, Riesen W, Wuthrich RP (2004) Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 61:98-102 (Pubitemid 38219904)
12. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P (2007) NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089-2095 (Pubitemid 350090716)
13. Chertow GM (1997) On the design and analysis of multicenter trials in acute renal failure. Am J Kidney Dis 30:S96-101 (Pubitemid 27465347)
14. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930-936 (Pubitemid 34454211)
15. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT (1983) Hospital-acquired renal insufficiency: A prospective study. Am J Med 74:243-248 (Pubitemid 13192180)
16. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254-261
17. Manske CL, Sprafka JM, Strony JT, Wang Y (1990) Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620 (Pubitemid 20384319)
18. Yoshioka T, Fogo A, Beckman JK (1992) Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008-1015
19. McCarthy CS, Becker JA (1992) Multiple myeloma and contrast media. Radiology 183:519-521
20. Rosenstock JL, Bruno R, Kim JK, Lubarsky L, Schaller R, Panagopoulos G, DeVita MV, Michelis MF (2008) The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrastinduced nephropathy. Int Urol Nephrol 40:749-755
21. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, Moses JW, Leon MB, Dangas G (2005) Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67:706-713 (Pubitemid 40139864)
22. Ahuja TS, Niaz N, Agraharkar M (2000) Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 54:11-14 (Pubitemid 30456799)
23. Ranucci M, Ballotta A, Kunkl A, De Benedetti D, Kandil H, Conti D, Mollichelli N, Bossone E, Mehta RH (2008) Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol 101:1112-1118
24. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515-1519 (Pubitemid 38749208)
25. Arakawa K, Suzuki H, Naitoh M, Matsumoto A, Hayashi K, Matsuda H, Ichihara A, Kubota E, Saruta T (1996) Role of adenosine in the renal responses to contrast medium. Kidney Int 49:1199-1206 (Pubitemid 26167274)
26. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C (1983) Relationship of renal hemodynamic and functional changes following intravascular contrast to the reninangiotensin system and renal prostacyclin in the dog. Invest Radiol 18:160-166
27. Seeliger E, Flemming B, Wronski T, Ladwig M, Arakelyan K, Godes M, Mockel M, Persson PB (2007) Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 18:2912-2920 (Pubitemid 350058398)
28. Weisberg LS, Kurnik PB, Kurnik BR (1992) Radiocontrastinduced nephropathy in humans: Role of renal vasoconstriction. Kidney Int 41:1408-1415
29. Mockel M, Radovic M, Kuhnle Y, Combe V, Waigand J, Schroder S, Dietz R, Frei U, Eckardt KU (2008) Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 23:1588-1594 (Pubitemid 351767743)
30. Heyman SN, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 3:288-296
31. Brezis M, Rosen S (1995) Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332:647-655
32. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M (1994) Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94:1069-1075 (Pubitemid 24286448)
33. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S (1991) Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40:632-642
34. Liss P, Nygren A, Erikson U, Ulfendahl HR (1998) Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 53:698-702 (Pubitemid 28124285)
35. Liss P, Carlsson PO, Palm F, Hansell P (2004) Adenosine A1 receptors in contrast media-induced renal dysfunction in the normal rat. Eur Radiol 14:1297-1302 (Pubitemid 38979225)
36. Agmon Y, Dinour D, Brezis M (1993) Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow. Am J Physiol 265:F802-806 (Pubitemid 2034506)
37. Kubo SH, Rector TS, Bank AJ (1996) Endothelial nitric oxide pathway function in the peripheral vasculature of patients with heart failure. J Card Fail 2:S217-223
38. Zoccali C (2006) Endothelial dysfunction and the kidney: Emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 17:S61-63
39. Calver A, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554 (Pubitemid 23010077)
40. Panza JA, Quyyumi AA, Callahan TS, Epstein SE (1993) Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 21:1145-1151 (Pubitemid 23106189)
41. Liss P, Carlsson PO, Nygren A, Palm F, Hansell P (2003) Et-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiol 44:111-117
42. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH (1992) Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58-65
43. Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance? Hypertension 44:248-252
44. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, Siamopoulos KC, Tsakiris D (2006) Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48:752-760 (Pubitemid 44740054)
45. White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin MC, Racine N, He Y, Yao G, Rouleau JL, Schiffrin EL, Touyz RM (2006) Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: Improvement after short-term inotropic support. Clin Sci (Lond) 110:483-489
46. Hayden MR, Whaley-Connell A, Sowers JR (2005) Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: Paying homage to the podocyte. Am J Nephrol 25:553-569 (Pubitemid 41819029)
47. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr (1990) Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol 258:F115-120 (Pubitemid 20063077)
48. Araujo M, Welch WJ (2006) Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 15:72-77 (Pubitemid 43755837)
49. Itoh Y, Yano T, Sendo T, Sueyasu M, Hirano K, Kanaide H, Oishi R (2006) Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. Kidney Int 69:288-297 (Pubitemid 43323079)
50. Schick CS, Haller C (1999) Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 14:342-347 (Pubitemid 29062788)
51. Peer A, Averbukh Z, Berman S, Modai D, Averbukh M, Weissgarten J (2003) Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, endothelial, and hepatic cells. Invest Radiol 38:177-182 (Pubitemid 36255290)
52. Haller C, Hizoh I (2004) The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 39:149-154 (Pubitemid 38263921)
53. Dobrota M, Powell CJ, Holtz E, Wallin A, Vik H (1995) Biochemical and morphological effects of contrast media on the kidney. Acta Radiol Suppl 399:196-203
54. Ueda J, Nygren A, Hansell P, Erikson U (1992) Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Acta Radiol 33:596-599
55. Ueda J, Nygren A, Hansell P, Ulfendahl HR (1993) Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 34:83-87 (Pubitemid 23079364)
56. Ueda J, Nygren A, Sjoquist M, Jacobsson E, Ulfendahl HR, Araki Y (1998) Iodine concentrations in the rat kidney measured by X-ray microanalysis. Comparison of concentrations and viscosities in the proximal tubules and renal pelvis after intravenous injections of contrast media. Acta Radiol 39:90-95 (Pubitemid 128459368)
57. Persson PB, Tepel M (2006) Contrast medium-induced nephropathy: The pathophysiology. Kidney Int Suppl 100:S8-10
58. Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD (2004) Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94:300-305 (Pubitemid 38962693)
59. Kane GC, Doyle BJ, Lerman A, Barsness GW, Best PJ, Rihal CS (2008) Ultra-low contrast volumes reduce rates of contrastinduced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol 51:89-90
60. Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL (2009) Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150:170-177
61. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178 (Pubitemid 23183119)
62. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499 (Pubitemid 36159884)
63. McCullough PA, Bertrand ME, Brinker JA, Stacul F (2006) A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48:692-699 (Pubitemid 44175706)
64. Heinrich MC, Haberle L, Muller V, Bautz W, Uder M (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: Meta-analysis of randomized controlled trials. Radiology 250:68-86
65. Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: A doubleblind comparison of iodixanol and iopamidol. Invest Radiol 41:815-821 (Pubitemid 44564026)
66. Kuhn MJ, Chen N, Sahani DV, Reimer D, van Beek EJ, Heiken JP, So GJ (2008) The PREDICT study: A randomized doubleblind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR Am J Roentgenol 191:151-157 (Pubitemid 351955220)
67. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H (2002) Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-336 (Pubitemid 34127411)
68. Solomon R, Werner C, Mann D, D'Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420 (Pubitemid 24348355)
69. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29-34
70. Weisbord SD, Bruns FJ, Saul MI, Palevsky PM (2004) Provider use of preventive strategies for radiocontrast nephropathy in high-risk patients. Nephron Clin Pract 96:c56-62
71. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 291:2328-2334 (Pubitemid 38656299)
72. Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M (2007) Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 100:781-786 (Pubitemid 47268267)
73. Hogan SE, L'Allier P, Chetcuti S, Grossman PM, Nallamothu BK, Duvernoy C, Bates E, Moscucci M, Gurm HS (2008) Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: A meta-analysis. Am Heart J 156:414-421
74. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F (2008) Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52:599-604
75. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS (2008) Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol 3:10-18
76. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agentinduced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184 (Pubitemid 30489215)
77. Efrati S, Dishy V, Averbukh M, Blatt A, Krakover R, Weisgarten J, Morrow JD, Stein MC, Golik A (2003) The effect of Nacetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int 64:2182-2187 (Pubitemid 37449553)
78. Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Lombardi M, Sagripanti S, Buratti S, Ardissino D, Cabassi A (2004) Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media. Nephrol Dial Transplant 19:865-869 (Pubitemid 38455657)
79. Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC (2004) Renal effects of Nacetylcysteine in patients at risk for contrast nephropathy: Decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 19:1803-1807 (Pubitemid 38961391)
80. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 289:553-558 (Pubitemid 37428626)
81. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354:2773-2782 (Pubitemid 43974195)
82. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ (2003) A rapid protocol for the prevention of contrastinduced renal dysfunction: The RAPPID study. J Am Coll Cardiol 41:2114-2118 (Pubitemid 36724254)
83. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407-410 (Pubitemid 38140781)
84. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA (2006) Acetylcysteine in the prevention of contrast-induced nephropathy: A case study of the pitfalls in the evolution of evidence. Arch Intern Med 166:161-166
85. Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER (2004) Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117:938-947 (Pubitemid 40075562)
86. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC (2008) Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148:284-294 (Pubitemid 351665489)
87. Fishbane S (2008) N-acetylcysteine in the prevention of contrastinduced nephropathy. Clin J Am Soc Nephrol 3:281-287
88. Vaitkus PT, Brar C (2007) N-acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-analyses. Am Heart J 153:275-280 (Pubitemid 46096863)
89. Kanter MZ (2006) Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 63:1821-1827
90. Katholi RE, Taylor GJ, McCann WP, Woods WT Jr, Womack KA, McCoy CD, Katholi CR, Moses HW, Mishkel GJ, Lucore CL, Holloway RM, Miller BD, Woodruff RC, Dove JT, Mikell FL, Schneider JA (1995) Nephrotoxicity from contrast media: Attenuation with theophylline. Radiology 195:17-22
91. Shammas NW, Kapalis MJ, Harris M, McKinney D, Coyne EP (2001) Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. J Invasive Cardiol 13:738-740 (Pubitemid 33759909)
92. Bagshaw SM, Ghali WA (2005) Theophylline for prevention of contrast-induced nephropathy: A systematic review and metaanalysis. Arch Intern Med 165:1087-1093 (Pubitemid 40720732)
93. Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining A, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM (2006) Prophylaxis of contrast material-induced nephropathy in patients in intensive care: Acetylcysteine, theophylline, or both? A randomized study. Radiology 239:793-804 (Pubitemid 43830615)
94. Gurkowski L, MacDougall M, Wiegmann T (1995) Effects of misoprostol on contrast-induced renal dysfunction. Am J Ther 2:837-842
95. Koch JA, Plum J, Grabensee B, Modder U (2000) Prostaglandin E1: A new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant 15:43-49 (Pubitemid 30037929)
96. Sketch MH Jr, Whelton A, Schollmayer E, Koch JA, Bernink PJ, Woltering F, Brinker J (2001) Prevention of contrast mediainduced renal dysfunction with prostaglandin E1: A randomized, double-blind, placebo-controlled study. Am J Ther 8:155-162
97. Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV (2004) Ascorbic acid prevents contrastmediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110: 2837-2842 (Pubitemid 39473606)
98. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 115:1211-1217 (Pubitemid 46594764)
99. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK (2002) Prospective randomized study of Nacetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57:279-283 (Pubitemid 35266257)
100. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 290:2284-2291 (Pubitemid 37430561)
101. Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J (1998) Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 64:432-436 (Pubitemid 28208787)
102. Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB (1999) Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 83(260-263):A265 (Pubitemid 29047309)
103. Weisberg LS, Kurnik PB, Kurnik BR (1994) Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259-265 (Pubitemid 24046017)
104. Gare M, Haviv YS, Ben-Yehuda A, Rubinger D, Bdolah-Abram T, Fuchs S, Gat O, Popovtzer MM, Gotsman MS, Mosseri M (1999) The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 34:1682-1688
105. Cacoub P, Deray G, Baumelou A, Jacobs C (1988) No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. Clin Nephrol 29:215-216
106. Russo D, Testa A, Della Volpe L, Sansone G (1990) Randomised prospective study on renal effects of two different contrast media in humans: Protective role of a calcium channel blocker. Nephron 55:254-257 (Pubitemid 20209507)
107. Carraro M, Mancini W, Artero M, Stacul F, Grotto M, Cova M, Faccini L (1996) Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transplant 11:444-448 (Pubitemid 26092782)
108. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31:674-680 (Pubitemid 28158009)
109. Miller HI, Dascalu A, Rassin TA, Wollman Y, Chernichowsky T, Iaina A (2003) Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: A randomized, parallel, double-blind clinical trial. Am J Nephrol 23:91-95 (Pubitemid 36164602)
110. Attallah N, Yassine L, Musial J, Yee J, Fisher K (2004) The potential role of statins in contrast nephropathy. Clin Nephrol 62:273-278 (Pubitemid 39386803)
111. Khanal S, Attallah N, Smith DE, Kline-Rogers E, Share D, O'Donnell MJ, Moscucci M (2005) Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 118:843-849 (Pubitemid 41097461)
112. Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, Youn TJ, Chung WY, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS (2008) Prevention of radiocontrast mediuminduced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study. Am Heart J 155:e491-498
113. Weinstein JM, Heyman S, Brezis M (1992) Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413-415
114. Anto HR, Chou SY, Porush JG, Shapiro WB (1981) Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 141:1652-1656
115. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ (2000) Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675-1680 (Pubitemid 30207926)
116. Schindler R, Stahl C, Venz S, Ludat K, Krause W, Frei U (2001) Removal of contrast media by different extracorporeal treatments. Nephrol Dial Transplant 16:1471-1474 (Pubitemid 32640606)
117. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P (1998) Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358-362 (Pubitemid 28062196)
118. Sterner G, Frennby B, Kurkus J, Nyman U (2000) Does postangiographic hemodialysis reduce the risk of contrast-medium nephropathy? Scand J Urol Nephrol 34:323-326 (Pubitemid 32056484)
119. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692-698 (Pubitemid 34017520)
120. Frank H, Werner D, Lorusso V, Klinghammer L, Daniel WG, Kunzendorf U, Ludwig J (2003) Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrastinduced nephropathy in chronic renal failure. Clin Nephrol 60:176-182 (Pubitemid 37121780)
121. Lee PT, Chou KJ, Liu CP, Mar GY, Chen CL, Hsu CY, Fang HC, Chung HM (2007) Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol 50:1015-1020
122. Gabutti L, Marone C, Monti M, Malfanti M, Zwahlen U, Pasotti E, Colucci G, Schonholzer C (2003) Does continuous venove- nous hemodiafiltration concomitant with radiological procedures provide a significant and safe removal of the iodinated contrast ioversol? Blood Purif 21:152-157 (Pubitemid 36302365)
123. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL (2003) The prevention of radiocontrast-agentinduced nephropathy by hemofiltration. N Engl J Med 349:1333-1340
124. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, Grazi M, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL (2006) Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 119:155-162 (Pubitemid 43151482)
125. Klarenbach SW, Pannu N, Tonelli MA, Manns BJ (2006) Costeffectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Crit Care Med 34:1044-1051
126. Younathan CM, Kaude JV, CookMD, Shaw GS, Peterson JC (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. AJR Am J Roentgenol 163:969-971
127. Hamani A, Petitclerc T, Jacobs C, Deray G (1998) Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis? Nephrol Dial Transplant 13:1051-1052 (Pubitemid 28161802)
128. Morcos SK, Thomsen HS, Webb JA (2002) Dialysis and contrast media. Eur Radiol 12:3026-3030
129. Sam AD 2nd, Morasch MD, Collins J, Song G, Chen R, Pereles FS (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313-318 (Pubitemid 41123255)
130. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311-318 discussion 328-329 (Pubitemid 34454302)
131. Thomsen HS (2005) How to avoid CIN: Guidelines from the European Society of Urogenital Radiology. Nephrol Dial Transplant 20[Suppl 1]:i18-22
132. Medwatch F (2006) Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Ominiscan, OptiMARK, Magnevist, ProHance, and MultiHance. Available at: FDA.GOV/medwatch/safety/2006/safety06.htm
133. Grobner T (2006) Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104-1108
134. Boyd AS, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56:27-30 (Pubitemid 44969309)
135. Penfield JG, Reilly RF (2008) Nephrogenic systemic fibrosis risk: Is there a difference between gadolinium-based contrast agents? Semin Dial 21:129-134
136. Solomon R, Deray G (2006) How to prevent contrast-induced nephropathy and manage risk patients: Practical recommendations. Kidney Int Suppl 69[Suppl S100]:S51-S53
137. Goldfarb S, McCullough PA, McDermott J, Gay SB (2009) Contrast-induced acute kidney injury: Specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 84:170-179
138. Arend LJ, Bakris GL, Burnett JC Jr, Megerian C, Spielman WS (1987) Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 110:406-411 (Pubitemid 18029904)
139. Erley C (2006) Concomitant drugs with exposure to contrast media. Kidney Int Suppl 69:S20-S24